Alpharma Responds To Unsolicited Proposal By King Pharmaceuticals, Inc.
- Details
- Category: Financial
Alpharma, Inc. (NYSE: ALO), a global specialty pharmaceutical company, confirmed that it received an unsolicited, non-binding proposal from King Pharmaceuticals, Inc. (NYSE: KG) to acquire all of the outstanding shares of Alpharma for $33.00 per share in cash. Alpharma said that proposal was identical in all material respects to two prior proposals made privately by King to the company.
King Proposes Acquisition of Alpharma for $33 Per Share in Cash
- Details
- Category: Financial
King Pharmaceuticals, Inc. (NYSE: KG) announced that it has submitted to the Board of Directors of Alpharma Inc. (NYSE: ALO) a proposal to acquire all of the outstanding shares of common stock of Alpharma for $33.00 per share in cash. The proposal is not conditioned on financing.
New Trial to Evaluate Nexavar® as Adjuvant Therapy in Liver Cancer
- Details
- Category: Bayer

Novo Nordisk joins the Call to Action for gender equality
- Details
- Category: Novo Nordisk

DAIICHI SANKYO continues its expansion in Germany and Europe
- Details
- Category: Daiichi Sankyo

Bristol-Myers Squibb and PDL BioPharma Enter Global Alliance
- Details
- Category: Bristol-Myers Squibb

Nycomed - strong results in second quarter 2008
- Details
- Category: Nycomed

More Pharma News ...
- Divestment of four Roche pharmaceutical products to Meda
- AstraZeneca and Abbott Expand Relationship to Include Co-Promotion of CRESTOR®
- Teva Reports Second Quarter 2008 Results - Record Quarterly Sales of $2,823 Million
- IAFF Launches Smoking Cessation Campaign with Pfizer
- Boehringer Ingelheim continued to post strong growth in local currencies in the first half of 2008
- Grindeks profit reaches 5 million lats in the first half of 2008
- PLIVA Announces H1 2008 Results